Each ml contains (Dexamethasone USP 1mg+ Neomycin Sulfate USP 3,500 IU+ Polymyxin B Sulfate USP 6,000 IU)
Neo-DP is indicated for the short term treatment of steroid responsive conditions of the eye when prophylactic antibiotic treatment is also required, after excluding the presence of fungal and viral disease.
Each ml contains (Dexamethasone USP 1mg+ Neomycin Sulfate USP 3,500 IU+ Polymyxin B Sulfate USP 6,000 IU)
Neo-DP is indicated for the short term treatment of steroid responsive conditions of the eye when prophylactic antibiotic treatment is also required, after excluding the presence of fungal and viral disease.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.